pov4-20

ONCOLOGY
BULLETIN
OF THE VOLGA REGION Vol. 11, no. 4. 2020
high-grade dysplasia from early adenocarcinoma in
Barrett’s esophagus // Gastroenterology. — 1993. —
Vol. 105. — P. 40-50.
15. Sampliner Richard E. Updated guidelines
for the diagnosis, surveillance, and therapy
of Barrett’s esophagus // The American journal
of gastroenterology. — 2002. — Vol. 97. —
P. 1888-1895.
16. Reid B.J., Levine D.S., Longton G., Blount P.L. et al.
Predictors of progression to cancer in Barrett’s
esophagus: baseline histology and flow cytometry
identify low- and high-risk patient subsets // The
American journal of gastroenterology. — 2000. —
Vol. 95. — P. 1669-1676.
17. Reid B.J., Blount P.L., Feng Z., Levine D.S. Optimizing
endoscopic biopsy detection of early cancers in
Barrett’s high-grade dysplasia // The American
journal of gastroenterology. — 2000. — Vol. 95. —
P. 3089-3096.
18. Weston A.P., Sharma P., Topalovski M.,
Richards R. et al. Long-term follow-up of Barrett’s
high-grade dysplasia // The American journal of
gastroenterology. — 2000. — Vol. 95. — P. 1888-1893.
19. Streitz J.M., Ellis F.H., Tilden R.L., Erickson R.V.
Endoscopic surveillance of Barrett’s esophagus: a
cost-effectiveness comparison with mammographic
surveillance for breast cancer // The American journal
of gastroenterology. — 1998. — Vol. 93. — P. 911-915.
20. Peters J.H., Clark G.W., Ireland A.P., Chandrasoma P.
et al. Outcome of adenocarcinoma arising in Barrett’s
esophagus in endoscopically surveyed and
nonsurveyed patients // The Journal of thoracic
and cardiovascular surgery. — 1994. — Vol. 108. —
P. 813-821; discussion 821-812.
21. Corley Douglas A., Levin Theodore R., Habel
Laurel A., Weiss Noel S. et al. Surveillance and survival
in Barrett’s adenocarcinomas: a population-based
study // Gastroenterology. — 2002. — Vol. 122. —
P. 633-640.
22. Fountoulakis A., Zafirellis K.D., Dolan K., Dexter S.P.L.
et al. Effect of surveillance of Barrett’s oesophagus
on the clinical outcome of oesophageal cancer //
The British journal of surgery. — 2004. — Vol. 91. —
P. 997-1003.
23. Streitz J.M., Andrews C.W., Ellis F.H. Endoscopic
surveillance of Barrett’s esophagus. Does it help? //
The Journal of thoracic and cardiovascular surgery. —
1993. — Vol. 105. — P. 383-387; discussion 387-388.
24. van Sandick J.W., van Lanschot J.J., Kuiken B.W.,
Tytgat G.N. et al. Impact of endoscopic biopsy
surveillance of Barrett’s oesophagus on pathological
stage and clinical outcome of Barrett’s carcinoma //
Gut. — 1998. — Vol. 43. — P. 216-222.
25. Incarbone R., Bonavina L., Saino G., Bona D. et al.
Outcome of esophageal adenocarcinoma detected
during endoscopic biopsy surveillance for Barrett’s
esophagus // Surgical endoscopy. — 2002. —
Vol. 16. — P. 263-266.
26. Ferguson Mark K., Amy Durkin. Long-term survival
after esophagectomy for Barrett’s adenocarcinoma
in endoscopically surveyed and nonsurveyed
patients // Journal of gastrointestinal surgery: official
journal of the Society for Surgery of the Alimentary
Tract. — 2002. — Vol. 6. — P. 29-35; discussion 36.
27. Shaheen Nicholas J., Crosby Melissa A., Bozymski
Eugene M., Sandler Robert S. Is there publication
bias in the reporting of cancer risk in Barrett’s
esophagus? // Gastroenterology. — 2000. —
Vol. 119. — P. 333-338.
28. Shaheen Nicholas, Ransohoff David F.
Gastroesophageal reflux, barrett esophagus, and
esophageal cancer: scientific review // JAMA: the
journal of the American Medical Association. —
2002. — Vol. 287. — P. 1972-1981.
29. Inadomi John M., Sampliner Richard, Lagergren
Jesper, Lieberman David et al. Screening and
surveillance for Barrett esophagus in high-risk
groups: a cost-utility analysis // Annals of internal
medicine. — 2003. — Vol. 138. — P. 176-186.
30. Gerson Lauren B., Groeneveld Peter W.,
Triadafilopoulos George. Cost-effectiveness model
of endoscopic screening and surveillance in patients
with gastroesophageal reflux disease // Clinical
gastroenterology and hepatology: the official clinical
practice journal of the American Gastroenterological
Association. — 2004. — Vol. 2. — P. 868-879.
31. Soni A., Sampliner R.E., Sonnenberg A. Screening
for high-grade dysplasia in gastroesophageal reflux
disease: is it cost-effective? // The American journal of
gastroenterology. — 2000. — Vol. 95. — P. 2086-2093.
32. Provenzale D., Schmitt C., Wong J.B. Barrett’s
esophagus: a new look at surveillance based on
emerging estimates of cancer risk // The American
journal of gastroenterology. — 1999. — Vol. 94. —
P. 2043-2053.
33. Spechler Stuart Jon. Should patients with GERD
be screened once at least for Barrett’s epithelium?
A balancing view: To screen or not to screen:
scoping out the issues // The American journal of
gastroenterology. — 2004. — Vol. 99. — P. 2295-2296.
Literature review
71